StockData
APTNOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

ADAPTIN BIO, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$6.27+0.00 (0.00%)

Close on Aug 19, 2026

Market cap
$55.48M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Adaptin Bio has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Adaptin Bio filed with the SEC